Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNE1 | P24864 | 3/20 | 0.33 |
| ▸ | CDK2 | P24941 | 3/20 | 0.33 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.33 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.33 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.33 |
| ▸ | IKBKB | O14920 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22262082 | 0.93 | CDK2 (0.33) | CCNE1CDK2CCNE2TLR8GRIA1 | |
| SCHEMBL22281206 | 0.85 | DRD1 (0.33) | IKBKBKDM4EALDH1A1LMNAHPGD | |
| SCHEMBL22280909 | 0.84 | BCHE (0.39) | TLR8KDM4EALDH1A1LMNAHPGD | |
| SCHEMBL22262081 | 0.81 | ESR1 (0.39) | CCNE1CDK2CCNE2ESR1ESR2 | |
| SCHEMBL20561490 | 0.81 | IKBKB (0.35) | CCNE1CDK2CCNE2TLR8GRIA1 | |
| SCHEMBL22280910 | 0.80 | KDM4E (0.34) | KDM4EALDH1A1LMNAHPGD | |
| SCHEMBL22280898 | 0.79 | GRIA1 (0.31) | CCNE1CDK2GRIA1IKBKB | |
| SCHEMBL22281107 | 0.78 | DRD1 (0.33) | IKBKBKDM4EALDH1A1LMNAHPGD | |
| SCHEMBL22280693 | 0.78 | RORA (0.35) | CCNE1CDK2CCNE2IKBKBALDH1A1 | |
| SCHEMBL22349169 | 0.76 | CCNE1 (0.37) | CCNE1CDK2CCNE2KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200239505-A1 | BLUE PHOSPHORESCENT EMITTERS EMPLOYING FUNCTIONALIZED IMIDAZOPHENTHRIDINE AND ANALOGUES | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2020-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200239505-A1 | BLUE PHOSPHORESCENT EMITTERS EMPLOYING FUNCTIONALIZED IMIDAZOPHENTHRIDINE AND ANALOGUES | EML4, TYR, TYMP | CCNE1 3005/4885CDK2 435/4885CCNE2 1501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.